Kibera is one of the largest slums in Kenya. Here, MSF offers care to a neglected population isolated from basic healthcare standards due to hardships of poverty, Kenya 2011. Photograph by Bruno De Cock
Press release |

MSF response to release of WHO’s Global Tuberculosis Report 2018

3 min
Photograph by Bruno De Cock
Kibera is one of the largest slums in Kenya. Here, MSF offers care to a neglected population isolated from basic healthcare standards due to hardships of poverty, Kenya 2011. Photograph by Bruno De Cock

Background:

New York, 18 September, 2018 — The World Health Organization (WHO) released its annual Global TB Report today, one week before heads of state will convene at the UN’s first-ever summit on tuberculosis (TB), the UN High-level Meeting on TB on September 26th.

The report highlights sluggish global progress on TB, indicating that countries will not be able to meet their targets in the ‘End TB’ strategy at this slow pace. TB remains the world’s leading infectious disease killer, taking 1.6 million lives in 2017 (compared to 1.7 million in 2016), with 10 million people developing TB in 2017 (about 10.4 million people had TB in 2016). Of grave concern are the prevailing gaps in diagnosing and treating people with TB: in 2017, 64% people with TB were diagnosed and their cases reported (compared to 61% in 2016). Among people with drug-resistant TB (DR-TB), 25% of people who were diagnosed were also treated (compared to 22% in 2016).

The WHO will also release new treatment guidelines for DR-TB this year, which will recommend using the newer drug bedaquiline as part of the core treatment regimen.


Sharonann Lynch, HIV & TB Policy Advisor, MSF Access Campaign:

“The latest TB epidemic figures are a shameful report card on the world’s failure to confront this curable disease that continues to kill more than a million and a half people each year. Governments continue to tackle the world’s deadliest infectious disease with lethal mediocrity.

"The world’s leaders must seize the opportunity of the first-ever TB summit to curb and reverse TB’s deplorable trajectory."

Sharonann Lynch
Senior HIV & TB Advisor
MSF Access Campaign

Seven years in a row now, about 40% of people with TB persistently remain undiagnosed, when we have the means to do so much better. If we’re not even diagnosing people with TB, how are they supposed to get treated?

The world’s leaders must seize the opportunity of the first-ever TB summit to curb and reverse TB’s deplorable trajectory. The TB summit must be a reckoning of these global failures and must not simply restate earlier promises to end TB by 2030. Such promises mean nothing if the governments do not commit to test and treat more people tomorrow and provide significant funding to bring out affordable new treatments, diagnostics and vaccines.

Millions of people with TB around the world are waiting for the political commitment to turn this epidemic around and stop the senseless deaths and suffering caused by the disease. It’s time to smash the TB status quo—what are we waiting for?”